Search Results - "Andrikos, E."

Five-year survival in comparable HD and PD patients: one center's experience by Andrikos, E, Tseke, P, Balafa, O, Pappas, M

“…Several studies have yielded conflicting results regarding morbidity and mortality in peritoneal dialysis (PD) and hemodialysis (HD) patients. We performed a…”
Get full text

Integration of blood volume, blood pressure, heart rate and bioimpedance monitoring for the achievement of optimal dry body weight during chronic hemodialysis by Bonello, M, House, A A, Cruz, D, Asuman, Y, Andrikos, E, Petras, D, Strazzabosco, M, Ronco, F, Brendolan, A, Crepaldi, C, Nalesso, F, Ronco, C

“…Achieving optimal dry body weight in hemodialysis is challenging. Clinical assessment alone is inadequate, and methods such as bioimpedance monitoring may be…”
Get full text

Evolution of Fabry disease in male patients: the Greek experience by Andrikos, E, Iatrou, C, Boletis, J N, Diamandopoulos, A, Katsinas, C, Kalaitzidis, K, Galinas, A, Xaidara, A, Pappas, M, Siamopoulos, K C

“…Fabry disease is a progressive metabolic disorder with a clinical course characterized by different phases and a variety of disease manifestations. The first…”
Get more information

Pulse high volume hemofiltration by Brendolan, A, D'Intini, V, Ricci, Z, Bonello, M, Ratanarat, R, Salvatori, G, Bordoni, V, De Cal, M, Andrikos, E, Ronco, C, Salvadori, G

“…The sepsis syndrome is the most common cause of acute renal failure and multiple organ dysfunction in critically ill subjects and continues to have an…”
Get full text

Effect of Cyclosporine, Mycophenolate Mofetil, and Their Combination With Steroids on Apoptosis in a Human Cultured Monocytic U937 Cell Line by Andrikos, E., Yavuz, A., Bordoni, V., Ratanarat, R., De Cal, M., Bonello, M., Salvatori, G., Levin, N., Yakupoglu, G., Pappas, M., Ronco, C.

“…Transplant patient plasma produces an increased rate of mononuclear cell apoptosis despite a normal serum creatinine value. Immunosuppressive medications may…”
Get full text

Effectiveness of Aluminum Hydroxide Timing Administration in Relation to Meals in Controling Hyperphosphatemia in Dialysis Patients by Katopodis, K.P., Andrikos, E., Pappas, M., Siamopoulos, K.C.

“…Phosphate binder compounds contribute to the control of hyperphosphatemia in hemodialysis (HD) patients. However, the most effective schedule of administration…”
Get full text

Pulse High Volume Hemofiltration by Brendolan, A., D'intini, V., Ricci, Z., Bonello, M., Ratanarat, R., Salvatori, G., Bordoni, V., De Cal, M., Andrikos, E., Ronco, C.

Get full text

Rapid elevation of transferrin saturation and serum hepcidin concentration in hemodialysis patients after intravenous iron infusion by Kitsati, Natalia, Liakos, Dimitrios, Ermeidi, Eleni, Mantzaris, Michalis D, Vasakos, Spyros, Kyratzopoulou, Eleni, Eliadis, Petros, Andrikos, Emilios, Kokkolou, Elisavet, Sferopoulos, Georgios, Mamalaki, Avgi, Siamopoulos, Konstantinos, Galaris, Dimitrios

Get full text

Uremic toxins: a new focus on an old subject by Yavuz, Asuman, Tetta, Ciro, Ersoy, F Fevzi, D'intini, Vincent, Ratanarat, Ranistha, De Cal, Massimo, Bonello, Monica, Bordoni, Valeria, Salvatori, Gabriella, Andrikos, Emilio, Yakupoglu, Gulsen, Levin, Nathan W, Ronco, Claudio

“…The uremic syndrome is characterized by an accumulation of uremic toxins due to inadequate kidney function. The European Uremic Toxin (EUTox) Work Group has…”
Get full text

Phosphate kinetics during different dialysis modalities by Ratanarat, Ranistha, Brendolan, Alessandra, Volker, Gopel, Bonello, Monica, Salvatori, Gabriella, Andrikos, Emilio, Yavuz, Asuman, Crepaldi, Carlo, Ronco, Claudio

“…An abnormal serum phosphate concentration is common in acute renal failure patients, with a reported incidence of 65-80%. Phosphate removal and kinetics during…”
Get more information

Effectiveness of aluminum hydroxide timing administration in relation to meals in controlling hyperphosphatemia in dialysis patients by Katopodis, K P, Andrikos, E, Pappas, M, Siamopoulos, K C

“…Phosphate binder compounds contribute to the control of hyperphosphatemia in hemodialysis (HD) patients. However, the most effective schedule of administration…”
Get full text

Rasburicase therapy in acute hyperuricemia and renal dysfunction by Ronco, Claudio, Inguaggiato, Paola, Bordoni, Valeria, De Cal, Massimo, Bonello, Monica, Andrikos, Emilios, Assuman, Yavuz, Rattanarat, Ranishta, Bellomo, Rinaldo

“…Neoplastic disorders may be complicated by acute renal failure (ARF). Different tumors may cause ARF: solid tumors involving the kidney, solid tumors not of…”
Get more information

A new machine for continuous renal replacement therapy: from development to clinical testing by Ricci, Zaccaria, Salvatori, Gabriella, Bonello, Monica, Ratanarat, Ranistha, Andrikos, Emilios, Dan, Maurizio, Piccinni, Pasquale, Ronco, Claudio

“…A new continuous renal replacement therapy machine has been designed to fulfill the expectations of nephrologists and intensivists operating in the common…”
Get more information

Effect of daily hemodialysis on monocytes apoptosis by Andrikos, Emilio, Buoncristiani, Emanuela, D'Intini, Vincenzo, Bordoni, Valeria, Bonello, Monica, Levin, Nathan, Buoncristiani, Umberto, Pappas, Michail, Ronco, Claudio

“…Uremia is associated with a state of immune dysfunction with increased susceptibility to infection and malignancy possibly related to dysregulation of immune…”
Get more information

Magnesium Homeostasis in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis: Role of the Dialysate Magnesium Concentration by Katopodis, Kostas P., Koliousi, Elli L., Andrikos, Emilios K., Pappas, Michael V., Elisaf, Moses S., Siamopoulos, Kostas C.

“…: We carried out this retrospective study to examine the magnesium status of our chronic ambulat‐ ory peritoneal dialysis (CAPD) patients dialyzed with 0.75…”
Get full text